Assenagon Asset Management S.A. Idera Pharmaceuticals, Inc. Transaction History

Assenagon Asset Management S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$0.32 - $0.74 $8,636 - $19,971	-26,989 Reduced 49.27%	27,784 $13,000
Q1 2022 Apr 25, 2022	BUY	$0.41 - $0.7 $22,456 - $38,341	54,773 New	54,773 $27,000
Q4 2021 Feb 01, 2022	SELL	$0.53 - $1.03 $7,148 - $13,892	-13,488 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$1.23 - $5.98 $2,065 - $10,040	-1,679 Reduced 11.07%	13,488 $18,000
Q4 2020 Feb 01, 2021	BUY	$2.09 - $5.18 $31,699 - $78,565	15,167 New	15,167 $55,000
Q2 2019 Aug 12, 2019	SELL	$2.37 - $3.97 $843,075 - $1.41 Million	-355,728 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$2.33 - $3.79 $140,995 - $229,344	-60,513 Reduced 14.54%	355,728 $907,000
Q4 2018 Jan 23, 2019	BUY	$2.77 - $9.38 $1.15 Million - $3.9 Million	416,241 New	416,241 $1.15 Million

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.